57 related articles for article (PubMed ID: 15906357)
1. SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC.
Giannelli G; Marinosci F; Trerotoli P; Volpe A; Quaranta M; Dentico P; Antonaci S
Int J Cancer; 2005 Nov; 117(3):506-9. PubMed ID: 15906357
[TBL] [Abstract][Full Text] [Related]
2. Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.
Finkelmeier F; Canli Ö; Peiffer KH; Walter D; Tal A; Koch C; Pession U; Vermehren J; Trojan J; Zeuzem S; Piiper A; Greten FR; Grammatikos G; Waidmann O
PLoS One; 2018; 13(7):e0200855. PubMed ID: 30011326
[TBL] [Abstract][Full Text] [Related]
3. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection.
Abbate V; Marcantoni M; Giuliante F; Vecchio FM; Gatto I; Mele C; Saviano A; Arciuolo D; Gaetani E; Ferrari MC; Giarretta I; Ardito F; Riccardi L; Nicoletti A; Ponziani FR; Gasbarrini A; Pompili M; Pola R
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498353
[TBL] [Abstract][Full Text] [Related]
4. Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma.
Fares S; Wehrle CJ; Hong H; Sun K; Jiao C; Zhang M; Gross A; Allkushi E; Uysal M; Kamath S; Ma WW; Modaresi Esfeh J; Linganna MW; Khalil M; Pita A; Kim J; Walsh RM; Miller C; Hashimoto K; Schlegel A; Kwon DCH; Aucejo F
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672535
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma Genetic Classification.
Lominadze Z; Shaik MR; Choi D; Zaffar D; Mishra L; Shetty K
Cancer J; 2023 Sep-Oct 01; 29(5):249-258. PubMed ID: 37796642
[TBL] [Abstract][Full Text] [Related]
6. Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
Parikh ND; Tayob N; Singal AG
J Hepatol; 2023 Jan; 78(1):207-216. PubMed ID: 36089157
[TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
Pelizzaro F; Cardin R; Penzo B; Pinto E; Vitale A; Cillo U; Russo FP; Farinati F
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34068786
[TBL] [Abstract][Full Text] [Related]
8. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
9. Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma.
Cai FF; Song YN; Lu YY; Zhang Y; Hu YY; Su SB
Aging (Albany NY); 2020 Jul; 12(14):14949-14965. PubMed ID: 32701483
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for the Early Detection of Hepatocellular Carcinoma.
Parikh ND; Mehta AS; Singal AG; Block T; Marrero JA; Lok AS
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2495-2503. PubMed ID: 32238405
[TBL] [Abstract][Full Text] [Related]
11. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
[TBL] [Abstract][Full Text] [Related]
12. Biomarker development for hepatocellular carcinoma early detection: current and future perspectives.
Sengupta S; Parikh ND
Hepat Oncol; 2017 Oct; 4(4):111-122. PubMed ID: 30191058
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for Hepatocellular Carcinoma.
Lou J; Zhang L; Lv S; Zhang C; Jiang S
Biomark Cancer; 2017; 9():1-9. PubMed ID: 28469485
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers.
Braicu C; Burz C; Berindan-Neagoe I; Balacescu O; Graur F; Cristea V; Irimie A
Gastroenterology Res; 2009 Aug; 2(4):191-199. PubMed ID: 27942274
[TBL] [Abstract][Full Text] [Related]
15. Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma.
Chen J; Qian Z; Li F; Li J; Lu Y
Gut Liver; 2017 Jan; 11(1):112-120. PubMed ID: 27458175
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis.
Zhang J; Shao C; Zhou Q; Zhu Y; Zhu J; Tu C
Mol Clin Oncol; 2015 Sep; 3(5):1165-1171. PubMed ID: 26623071
[TBL] [Abstract][Full Text] [Related]
17. Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma.
Khattab M; Fouad M; Ahmed E
World J Hepatol; 2015 Oct; 7(23):2474-81. PubMed ID: 26483869
[TBL] [Abstract][Full Text] [Related]
18. Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC.
Toyoda H; Kumada T; Tada T; Sone Y; Kaneoka Y; Maeda A
Liver Cancer; 2015 Mar; 4(2):126-36. PubMed ID: 26020034
[TBL] [Abstract][Full Text] [Related]
19. Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
Li J; Cheng ZJ; Liu Y; Yan ZL; Wang K; Wu D; Wan XY; Xia Y; Lau WY; Wu MC; Shen F
Oncotarget; 2015 Apr; 6(11):9551-63. PubMed ID: 25871387
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Hu B; Tian X; Sun J; Meng X
Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
